Healthy Female Army
No Result
View All Result
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
No Result
View All Result
Healthy Female Army
No Result
View All Result
Home Healthcare

FDA allows first ever menthol e-cigarettes to be sold in US

by
June 21, 2024
in Healthcare
0
FDA allows first ever menthol e-cigarettes to be sold in US
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

The Food and Drug Administration (FDA) on Friday authorized the first ever nontobacco flavored electronic cigarettes for adult smokers, a sign the agency believes some flavors of vaping products can be used to mitigate the effects of smoking traditional cigarettes. 

The agency said it authorized four menthol products from NJOY, which was purchased in 2023 by tobacco giant Altria, manufacturer of Marlboro cigarettes.  

Including the four authorized Friday, the FDA has authorized the sale of only 27 e-cigarette products. All other products have been tobacco flavored, which isn’t widely used by young people.

The FDA stressed that the decision was specific only to the four devices authorized and not for any other menthol-flavored e-cigarette products.

Close

Thank you for signing up!

Subscribe to more newsletters here

The latest in politics and policy.
Direct to your inbox.
Sign up for the Health Care newsletter



“Based upon our rigorous scientific review, in this instance, the strength of evidence of benefits to adult smokers from completely switching to a less harmful product was sufficient to outweigh the risks to youth,” said Matthew Farrelly, director of the office of science in the FDA’s Center for Tobacco Products. 

Additionally, the agency said the authorization does not mean the products are safe and advised nontobacco users against using them. 

The FDA cited evidence submitted by the company that showed the menthol products provided a benefit for adults who smoke traditional cigarettes and want to switch, because it reduces their exposure to harmful chemicals. 

The agency is overdue in its task of reviewing premarket tobacco product applications, which are required for new tobacco products to be legally marketed in the U.S. The FDA previously said it would finish reviewing applications by the end of 2023 but missed that deadline. 

The agency’s action Friday was met with disappointment by leading vaping critics, including anti-tobacco groups and lawmakers, who have been pressing the FDA to ban flavors completely. 

“Today’s decision is hard to understand in light of the FDA’s own repeated conclusions that flavored e-cigarettes, including menthol-flavored products, appeal to kids and have fueled the youth e-cigarette epidemic. What has changed?” said Yolonda Richardson, president and CEO of the Campaign for Tobacco-Free Kids. “The evidence is clear that menthol is a flavor that appeals to and is widely used by kids.” 

The FDA’s authorization comes at a time when the U.S. government delayed a ban on menthol cigarettes, potentially indefinitely. 

Sen. Dick Durbin (D-Ill.), who held a hearing last week blasting the FDA for its inaction on vaping regulation, echoed Richardson’s concerns. 

“Today’s authorization of menthol-flavored vapes will create an opening for more children to become addicted to harmful products,” Durbin said. “Flavors like menthol are used by Big Tobacco companies to mask the harsh taste of their dangerous products. FDA knows this from its own experience seeking to ban the production of menthol cigarettes to protect the public health.” 

Previous Post

Democrats introduce bill to repeal Comstock abortion law, guard against Trump actions

Next Post

WHO warns of fake Ozempic

Next Post
WHO warns of fake Ozempic

WHO warns of fake Ozempic

  • Trending
  • Comments
  • Latest
Vaccine protection against COVID-19 related issues

Vaccine protection against COVID-19 related issues

April 26, 2022
2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

October 31, 2023
Religious services may lower risk of ‘deaths of despair’

Religious services may lower risk of ‘deaths of despair’

April 26, 2022
Signaling molecule may prevent Alzheimer’s

Signaling molecule may prevent Alzheimer’s

April 26, 2022
Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats

Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats

0
7 Tips to Make Your Workout Routine More Sustainable

7 Tips to Make Your Workout Routine More Sustainable

0
11 Weight Loss Tips That Will Get you Fast Results

11 Weight Loss Tips That Will Get you Fast Results

0
What are the Sunday Scaries? Plus, Here’s How to Beat Them

What are the Sunday Scaries? Plus, Here’s How to Beat Them

0
Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats

Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats

June 23, 2025
Abortions continued rising in 2024 despite state bans: report

Abortions continued rising in 2024 despite state bans: report

June 23, 2025
Abbott signs MAHA measure requiring food warning labels in Texas

Abbott signs MAHA measure requiring food warning labels in Texas

June 23, 2025
Delaware governor signs executive order protecting gender-affirming care

Delaware governor signs executive order protecting gender-affirming care

June 21, 2025

Recent News

Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats

Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats

June 23, 2025
Abortions continued rising in 2024 despite state bans: report

Abortions continued rising in 2024 despite state bans: report

June 23, 2025
Abbott signs MAHA measure requiring food warning labels in Texas

Abbott signs MAHA measure requiring food warning labels in Texas

June 23, 2025
Delaware governor signs executive order protecting gender-affirming care

Delaware governor signs executive order protecting gender-affirming care

June 21, 2025
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.

No Result
View All Result
  • Contact Us
  • Email Whitelisting
  • Home 1
  • Privacy Policy
  • Terms and Conditions
  • Terms and Conditions

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.